We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03658772
Brief Title: Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer

First Submitted : August 24, 2018
First Submitted that Met QC Criteria : September 3, 2018
First Posted : September 5, 2018

Last Update Submitted that Met QC Criteria : April 21, 2022
Last Update Posted : April 22, 2022